Open Access

Clinical value of combined detection of miR‑1202 and miR‑195 in early diagnosis of cervical cancer

  • Authors:
    • Xielan Yang
    • Zhiling Yan
    • Hongying Yang
    • Huijing Ni
    • Lei Zhang
    • Yufeng Wang
  • View Affiliations

  • Published online on: January 22, 2019     https://doi.org/10.3892/ol.2019.9956
  • Pages: 3387-3391
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The clinical value of the combined detection of miR‑1202 and miR‑195 in the early diagnosis of cervical cancer was studied. A retrospective analysis of 70 cervical cancer patients treated in the The Third Affiliated Hospital of Kunming Medical University and Yunnan Cancer Hospital from October 2015 to December 2017 was performed, and the lesion tissues were used as the experimental group. Normal cervical tissues from another 67 healthy females confirmed by physical examination at the same period were selected as the control group. The FIGO staging criteria were used for staging of the cervical cancer patients, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) method was used for the detection of the expression of miR‑1202 and miR‑195 in different tissues, and the receiver operating curve (ROC) was used for the analysis of the application values of miR‑1202 and miR‑195 diagnosis alone and their combined diagnosis in early cervical cancer patients. The levels of miR‑1202 and miR‑195 in the experimental group were lower than those in the control group (P<0.05). The differences were significant in the different stages of cervical cancer tissues (P<0.05). The later the staging of cervical cancer tissues were, the lower the levels of miR‑1202 and miR‑195 were. The sensitivities and area under the curve (AUC) values of miR‑1202 and miR‑195 in the combined diagnosis of early cervical cancer were significantly higher than those of miR‑1202 and miR‑195 alone. The expression levels of miR‑1202 and miR‑195 in the cervical cancer patients are different in different stages. Guiding clinical treatment and prognosis according to the results of combined detection is beneficial for the development of treatment for cervical cancer patients and for prognostic judgement, worthy of popularization and application.
View Figures
View References

Related Articles

Journal Cover

March-2019
Volume 17 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang X, Yan Z, Yang H, Ni H, Zhang L and Wang Y: Clinical value of combined detection of miR‑1202 and miR‑195 in early diagnosis of cervical cancer . Oncol Lett 17: 3387-3391, 2019
APA
Yang, X., Yan, Z., Yang, H., Ni, H., Zhang, L., & Wang, Y. (2019). Clinical value of combined detection of miR‑1202 and miR‑195 in early diagnosis of cervical cancer . Oncology Letters, 17, 3387-3391. https://doi.org/10.3892/ol.2019.9956
MLA
Yang, X., Yan, Z., Yang, H., Ni, H., Zhang, L., Wang, Y."Clinical value of combined detection of miR‑1202 and miR‑195 in early diagnosis of cervical cancer ". Oncology Letters 17.3 (2019): 3387-3391.
Chicago
Yang, X., Yan, Z., Yang, H., Ni, H., Zhang, L., Wang, Y."Clinical value of combined detection of miR‑1202 and miR‑195 in early diagnosis of cervical cancer ". Oncology Letters 17, no. 3 (2019): 3387-3391. https://doi.org/10.3892/ol.2019.9956